U.S. hospital to discharge doctor treated with experimental Ebola drug | Reuters.

Administrator Note:  This is wonderful news, the experimental drug ZMapp, manufactured by U.S. based Mapp Biopharmaceuticals was successful in treating Dr. Kent Brantly and he will be released from Emory University Hospital following a news conference today.

Nancy Writebol’s condition will also be discussed at the news conference.  Both patients had contracted Ebola in Liberia and were brought to the United States for treatment with this experimental drug.